# IDEXX Laboratories

收入38.1亿美元（2024财年）的兽医诊断龙头，其参比实验室网络和VetConnect Plus软件将PCR与抗原结果推送至诊所；2026年5月将Fecal Dx扩展至带绦虫，包括人兽共患的Echinococcus。

Source: https://cn.bioecon.ru/companies/idexx-laboratories/
Updated: 2026-07-01

- 国家: United States
- 代码: IDXX

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 生产基地 | 生产和分销设施位于美国缅因州韦斯特布鲁克、缅因州斯卡伯勒、佐治亚州罗斯韦尔、田纳西州孟菲斯，以及荷兰、瑞士、法国和英国。IDEXX 还计划在北卡罗来纳州威尔逊建立生产设施。 | https://ir.idexx.com/sec-filings/all-sec-filings/content/0000874716-26-000066/0000874716-26-000066.pdf, https://stocklight.com/stocks/us/nasdaq-idxx/idexx-laboratories/annual-reports/nasdaq-idxx-2025-10K-25648543.pdf, https://www.ci-designinc.com/project-1-2-1-2/idexx-horizon-center |
| 认证 | 生产及分销设施均通过ISO 9001质量标准认证,部分其他设施通过ISO 14001(环境)及ISO 17025(检测与校准)认证。 | https://ir.idexx.com/sec-filings/all-sec-filings/content/0000874716-26-000066/0000874716-26-000066.pdf, https://stocklight.com/stocks/us/nasdaq-idxx/idexx-laboratories/annual-reports/nasdaq-idxx-2025-10K-25648543.pdf |
| 监管批准 | 产品受USDA/APHIS监管(兽用生物制品需产品批准及设施许可)以及FDA监管(兽用医疗器械)。部分水质检测产品已获EPA批准。 | https://ir.idexx.com/sec-filings/all-sec-filings/content/0000874716-26-000066/0000874716-26-000066.pdf, https://stocklight.com/stocks/us/nasdaq-idxx/idexx-laboratories/annual-reports/nasdaq-idxx-2025-10K-25648543.pdf |
| 员工人数 | 截至2025年12月31日约有11,000名员工。 | https://ir.idexx.com/news-events/press-releases/detail/95/idexx-laboratories-announces-fourth-quarter-and-full-year-2024-results, https://ir.idexx.com/sec-filings/all-sec-filings/content/0000874716-26-000066/0000874716-26-000066.pdf |
| 营收 | 3.898 billion美元(USD)（2024财年）。 | https://ir.idexx.com/news-events/press-releases/detail/95/idexx-laboratories-announces-fourth-quarter-and-full-year-2024-results |

独立来源: ci-designinc.com, ir.idexx.com, stocklight.com

## 技术

- [One Health — 人兽共患病与耐药性监测服务](https://cn.bioecon.ru/technology/one-health-zoonosis-amr-monitoring/)